iifl-logo

DSP Healthcare Fund IDCW

DSP Healthcare Fund IDCW

Fund Name

DSP Mutual Fund

Scheme Name

DSP Healthcare Fund IDCW

AMC

DSP Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

12-Nov-2018

Fund Manager

Chirag Dagli

Net Assets (Rs. cr)

3514.02

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

DSP Healthcare Fund IDCW - Nav Details

Nav Date

:  21-Jul-2026

NAV [Rs.]

:  25.557

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

1.00% - If redeemed/switched out within 12 months from the date of allotment. Nil - If redeemed/switched out after 12 months from the date of allotment.

DSP Healthcare Fund IDCW- NAV Chart

DSP Healthcare Fund IDCW- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
-0.47
6.86
16.53
17.01
9.6
20.91
14.74
21.43
Category Avg
0.91
5.45
15.67
20.51
12.44
22.32
14.59
17.3
Category Best
1.68
7.29
20.63
29.94
21.15
26.24
17.44
31.98
Category Worst
-0.7
2.79
8.96
10.41
4.07
18.61
11.05
5.8

DSP Healthcare Fund IDCW- Latest Dividends

Record DateDividend %Bonus
24-Feb-2026190

DSP Healthcare Fund IDCW- Investment Details

Min. Investment(Rs.)

100

Increm.Investment(Rs.)

100

In & Out

In

InName Of The CompanyNo Of Shares
Syngene Intl.11,07,277

Out

InName Of The CompanyNo Of Shares
Laurus Labs9,14,169

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquityCiplaPharmaceuticals & Biotechnology8.352001379293.28
EquityIpca Labs.Pharmaceuticals & Biotechnology8.211696381288.55
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology8.141535592286.00
Foreign EquityIllumina IncHealthcare Services7.59160400266.79
EquitySai LifePharmaceuticals & Biotechnology6.881957356241.59
EquityGland PharmaPharmaceuticals & Biotechnology6.54920673229.70
Foreign EquityGlobus Medical IncHealthcare Equipment & Supplies5.72268800200.90
EquityApollo HospitalsHealthcare Services4.81194767169.09
EquityCohance LifePharmaceuticals & Biotechnology4.133179881145.05
EquityVijaya Diagnost.Healthcare Services3.60935530126.53
EquityAlembic PharmaPharmaceuticals & Biotechnology3.381442516118.68
EquityKovai MedicalHealthcare Services2.87168005100.77
EquityP & G Health LtdPharmaceuticals & Biotechnology2.87159288100.77
EquityAlkem LabPharmaceuticals & Biotechnology2.6116479091.78
EquityPfizerPharmaceuticals & Biotechnology2.5320064489.07
EquityIndoco RemediesPharmaceuticals & Biotechnology2.21324568277.64
Foreign EquityIntuitive Surgical IncHealthcare Equipment & Supplies2.011876870.60
EquityConcord BiotechPharmaceuticals & Biotechnology1.8149668863.58
EquityUnichem Labs.Pharmaceuticals & Biotechnology1.46111061651.27
EquitySyngene Intl.Healthcare Services1.38110727748.66
EquityNephrocare HealtHealthcare Services1.2263498343.01
EquityICICI LombardInsurance1.2024141342.04
EquityAarti DrugsPharmaceuticals & Biotechnology0.9285215532.20
Foreign EquityAbbott LaboratoriesPharmaceuticals & Biotechnology0.773160027.12
EquityJupiter Life LinHealthcare Services0.389411713.37
EquityEmcure PharmaPharmaceuticals & Biotechnology0.376996612.84
EquityLaxmi DentalHealthcare Equipment & Supplies0.182804016.30
Foreign EquityGrail IncHealthcare Services0.1687335.63

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
DSP Mutual Fund
Incorporation Date:
13-May-1996
Total Assets Managed (Cr.):
2,33,296.26
Trustee/s:
Mr.T.S. Krishna Murthy, DSP Trustee Private Limit, Shitin D. Desai, S.S.N. Moorthy, Mrs. Pravin tripathi, Ms. Dharmishta Rawal
Chairman:
NA
CEO / MD:
Mr. Kalpen Parekh
CIO:
NA
President:
NA
Director/s:
Uday Khanna, Mr.Hemendra M. Kothari, Mr. S.S. Mundra, Ms. Aditi Kothari Desai, Mr.Dhananjay Mungale, Mr. S. Ramadorai
Compliance Officer/s:
Pritesh Majmudar
Investor Service Officer/s:
NA
Fund Manager/s:
Chirag Dagli
Auditors:
S.R. BATLIBOI &Co.LLP, M/s.Walker Chandiok & Co.

OTHER INFORMATION

Registered Office:
The Ruby, 25th Floor, 29, Senapati Bapat Marg, Dadar (West), Mumbai - 400028.
Contact Nos:
022-66578000
Fax:
022-66578181
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.